Zoxakind 500 Tablet contains Nitazoxanide 500 mg, an antiprotozoal and broad-spectrum antimicrobial agent indicated for the treatment of various parasitic infections, including giardiasis, amoebiasis, and cryptosporidiosis. Nitazoxanide acts by interfering with the pyruvate:ferredoxin oxidoreductase enzyme-dependent electron transfer reaction, essential to anaerobic energy metabolism in susceptible protozoa and anaerobic bacteria, thereby inhibiting their growth and replication. Zoxakind 500 is effective against intestinal protozoa and certain helminths, making it a valuable option in managing gastrointestinal infections caused by protozoal pathogens. The tablet is typically administered orally, with dosing regimens tailored according to the specific infection and patient age. It is generally well tolerated, with common adverse effects including mild gastrointestinal disturbances such as nausea, abdominal pain, and diarrhea. Caution is advised in patients with known hypersensitivity to Nitazoxanide or any excipients in the formulation. Zoxakind 500 should be used under medical supervision, especially in pregnant or lactating women, and in patients with hepatic or renal impairment. Its broad-spectrum activity and favorable safety profile make Zoxakind 500 an effective therapeutic option in the management of protozoal infections.